20-PERCENT 9 YEAR SURVIVAL AFTER HIGH-DOSE THERAPY (HDT)+ -ABMT FOR HIGH-RISK MYELOMA (MM)LESS-THAN-OR-EQUAL-TO-AGE-50 OR B2M-LESS-THAN-OR-EQUAL-TO-2.5 MG/L PRE-HDT/

Authors
JAGANNATH S TRICOT G DESIKAN KR NAUCKE S MATTOX S DICKE K BARLOGIE B
Citation
S. Jagannath et al., 20-PERCENT 9 YEAR SURVIVAL AFTER HIGH-DOSE THERAPY (HDT)+ -ABMT FOR HIGH-RISK MYELOMA (MM)LESS-THAN-OR-EQUAL-TO-AGE-50 OR B2M-LESS-THAN-OR-EQUAL-TO-2.5 MG/L PRE-HDT/, Blood, 88(10), 1996, pp. 509-509
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
509 - 509
Database
ISI
SICI code
0006-4971(1996)88:10<509:29YSAH>2.0.ZU;2-C